Swidar (Fansidar) Tablets

Effective Antimalarial Treatment

Overview

Swidar (Fansidar) Tablets are a potent antimalarial medication, combining sulfadoxine and pyrimethamine to provide effective treatment and prevention of malaria caused by Plasmodium falciparum. This medication is especially valuable in areas with resistance to other antimalarials.

Key Features

• Powerful Combination: Contains sulfadoxine (500 mg) and pyrimethamine (25 mg) to inhibit parasitic enzymes and prevent the growth of malaria parasites.
• Targeted Action: Specifically formulated to treat and prevent malaria, particularly effective against drug-resistant strains.
• Wide Application: Used both for treatment and as a prophylactic measure in high-risk areas.

Benefits

• Rapid Relief: Quickly reduces symptoms of malaria, such as fever, chills, and flu-like illness.
• Prevention of Malaria: Can be used prophylactically to prevent the onset of malaria in travelers and residents of endemic areas.
• High Efficacy: Demonstrates significant efficacy where other treatments may fail due to resistance.

Recommended Use

• Dosage: Adults typically take 3 tablets as a single dose. Dosage for children is adjusted based on body weight.
• Administration: Taken orally with water. It can be administered with or without food.

Safety Information

• Monitoring Required: Regular blood tests are recommended to monitor for side effects.
• Side Effects: Can include allergic reactions, and in rare cases, severe cutaneous adverse reactions.
• Pregnancy and Nursing: Consultation with a healthcare provider is recommended before use during pregnancy or breastfeeding.

Swidar (Fansidar) Tablets are an essential part of the malaria treatment and prevention toolkit, especially suited for regions facing resistance to conventional antimalarial drugs.

--